Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL28322647 | 0.90 | ALDH1A1 (0.69) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| 1-Pentanol SCHEMBL11280714 | 0.90 | SMN1; SMN2 (0.75) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| Hexane SCHEMBL6745539 | 0.90 | SMN1; SMN2 (0.53) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| Propanol SCHEMBL1433302 | 0.89 | — | — | |
| 1-Pentanol SCHEMBL28908456 | 0.88 | SMN1; SMN2 (0.71) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| Hexane SCHEMBL28543105 | 0.88 | ALDH1A1 (0.65) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| Nonanol SCHEMBL12275209 | 0.88 | ALDH1A1 (0.77) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| 1-Hexanol SCHEMBL9796428 | 0.88 | ALDH1A1 (0.77) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| 1-Heptanol SCHEMBL6171012 | 0.88 | ALDH1A1 (0.77) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 | |
| Octanol SCHEMBL467972 | 0.88 | ALDH1A1 (0.77) | SMN1; SMN2TSHRLMNAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5389612-A | Treating infections caused by clostridium histolyticum and pseudomonas aeruginosa; enzyme inhibitors | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1995-02-14 | — | — | US | disclosed |